In a report issued on April 9, Richard Close from Canaccord Genuity maintained a Buy rating on Health Catalyst (HCAT), with a price target of $40.00. The
In a report issued on April 9, Richard Close from Canaccord Genuity maintained a Buy rating on Health Catalyst (HCAT

IFR US ECM Calendar

01:05pm, Thursday, 09'th Apr 2020
NEW YORK, April 9 (IFR) -
Health Catalyst, Inc. (HCAT) (the “Company” or “Health Catalyst”) announced today the pricing of $200.0 million aggregate principal amount of 2.50% convertible senior notes due 2025 (the “n

IFR US ECM Calendar

09:57pm, Wednesday, 08'th Apr 2020
NEW YORK, April 8 (IFR) -
Fly Intel: Pre-market Movers EHTH NVAX PINS UPS FDX RPM SGH GNMK TLGT AMC HCAT GLUU IQ W
Health Catalyst, Inc. (HCAT) (the “Company” or “Health Catalyst”) announced today that it intends to offer, subject to market conditions and other factors, $175.0 million aggregate principal
Janus Henderson Group PLC increased its position in shares of Health Catalyst (NASDAQ:HCAT) by 4.1% during the fourth quarter, according to the company in its most recent Form 13F filing with the Secu
Exact Sciences (NASDAQ:EXAS) initiated with an Outperform rating and a $70 (25% upside) price target at Evercore ISI.Health Catalyst (NASDAQ:HCAT) initiated with a Buy rating and a $40 (47% upside) pr
Analysts have been eager to weigh in on the Technology sector with new ratings on Health Catalyst (HCAT) and Okta (OKTA). Health Catalyst (HCAT) Canaccord
Analysts have been eager to weigh in on the Technology sector with new ratings on Health Catalyst ( HCAT – Research Report ) and Okta ( OKTA – Research Report ). Health Catalyst (HCAT) Canaccord G
Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced meaningful developments in its in
In a report released today, Sandy Draper from SunTrust Robinson maintained a Buy rating on Health Catalyst (HCAT), with a price target of $35.00. The
In a report released today, Sandy Draper from SunTrust Robinson maintained a Buy rating on Health Catalyst ( HCAT – Research Report ), with a price target of $35.00 . The company’s shares closed l

3 Healthcare Stocks to Buy for AI and Big Data

05:15pm, Thursday, 26'th Mar 2020
Healthcare stocks are in the spotlight as the coronavirus brings to light the importance of collecting data and using it to predict outcomes.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE